⌘K

Home/Filings/4/0000874015-25-000098

4//SEC Filing

BENNETT C FRANK 4

Accession 0000874015-25-000098

CIK 0000874015other

View on SEC.gov Company Profile

Filed

Mar 3, 7:00 PM ET

Accepted

Mar 4, 5:16 PM ET

Size

4.9 KB

Accession

0000874015-25-000098

Insider Transaction Report

Form 4

Period: 2025-02-28

IONIS PHARMACEUTICALS INCIONS

BENNETT C FRANK

EVP, Chief Scientific Officer

Transactions

Other
Common Stock
2025-02-28$28.21/sh+320$9,028→ 93,466 total

Footnotes (1)

[F1]Reporting shares purchased under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on February 28,2025. These shares may not be sold until August 28, 2025.

Documents

1 file

4
edgardoc.xmlPrimary
PRIMARY DOCUMENT

Issuer

IONIS PHARMACEUTICALS INC

CIK 0000874015

Entity typeother

IncorporatedDE

Related Parties

1

filerCIK 0001073387

Filing Metadata

Form type: 4
Filed: Mar 3, 7:00 PM ET
Accepted: Mar 4, 5:16 PM ET
Size: 4.9 KB

View on SEC.gov